The latest coronavirus developments and scientific research on prevention and treatment.
After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists…. read more.
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests. The study, published today in The Lancet… read more.
Donor hearts from people who were COVID-19-positive appeared to be as safe for transplantation as those from people without COVID-19, according to a short-term analysis to be presented… read more.
In the first study of its kind, German researchers have shown that the COVID pandemic saw a huge drop in the number of patients being admitted to hospital… read more.
A new screening test app could help advance the early detection of Parkinson’s disease and severe COVID-19, improving the management of these illnesses. Developed by a research team… read more.
A large two-year study has found that young people infected with SARS-CoV-2 – the virus which causes Covid-19 – are at increased risk of new-onset type 1 diabetes…. read more.
The European Medicines Agency has approved new Covid-19 vaccines that protect against the original SARS-CoV-2 virus and omicron variants. These adapted vaccines are the first updated versions of… read more.
Since 2020, the Covid-19 pandemic has led to a global increase in the number of people wearing masks to limit the spread of illness. Now, new research co-authored… read more.
A McMaster University-led study has found that most people infected with the SARS-CoV2 virus recover within 12 months, irrespective of the severity. However, although 75 per cent had… read more.
Persons infected with the COVID-19 virus are at an increased risk of developing neurological conditions in the first year after infection, researchers reported on Sept. 22 in Nature… read more.
Older people who were infected with COVID-19 show a substantially higher risk—as much as 50% to 80% higher than a control group—of developing Alzheimer’s disease within a year,… read more.
Starting twice daily flushing of the mucus-lined nasal cavity with a mild saline solution soon after testing positive for COVID-19 can significantly reduce hospitalization and death, investigators report…. read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
